|
Volumn 11, Issue 3, 2005, Pages 227-242
|
Clinical outcomes after discontinuation of Lamivudine in chronic hepatitis B patients with Lamivudine resistant HBV mutant
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
ADENINE;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BLOOD;
DRUG EFFECT;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
VIROLOGY;
ADENINE;
ADULT;
ANTIVIRAL AGENTS;
DRUG RESISTANCE, VIRAL;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT OUTCOME;
|
EID: 33644906967
PISSN: 1738222X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|